Can a frankincense cream shield skin from radiation burns?
NCT ID NCT07778290
First seen Aug 21, 2026 · Last updated Aug 21, 2026
Summary
This trial tests whether a cream made from Boswellia serrata (Indian olibanum) gum resin can prevent the painful skin irritation that often occurs during radiation therapy for head and neck cancer. Adults with head and neck cancer scheduled for radiation will apply the 2% cream to the treated skin area twice daily throughout their radiotherapy course. The study compares them to a group receiving no preventive cream, measuring how many need extra treatments for skin reactions and whether their skin improves or worsens.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A 2% cream made from Boswellia serrata (Indian olibanum) gum resin, applied to the skin in the radiation area twice daily during radiotherapy.
- What this could lead to
- If effective, this cream could offer a simple, natural way to prevent painful skin reactions during radiation therapy, improving comfort and reducing treatment interruptions.
- What could go wrong
- This is a small, early-stage trial, and the cream may not work better than no treatment. Skin irritation or allergic reactions are possible, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2026
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- Inclusion Criteria: * Adults aged 18 years or older, of any sex, with histologically confirmed head and neck cancer for which radiotherapy is indicated * Planned external-beam radiotherapy to the head and neck region (curative or adjuvant intent) with a planned total dose of at least 60 Gy; concurrent chemotherapy is permitted * Able to provide written informed consent and comply with the protocol (twice-daily cream application, follow-up visits, and a skin diary) * Agreement to avoid other topical treatments in the radiation field during the study period (except study-provided or allowed rescue medication) Exclusion Criteria: * Previous radiotherapy to the same site * Previous extensive surgery or reconstruction in the head and neck region that substantially alters the radiation field or interferes with skin assessment * Known allergy or hypersensitivity to Boswellia serrata, boswellic acids, or any component of the cream base * Current use of systemic corticosteroids or anti-inflammatory medications that could influence skin reactions (low-dose corticosteroids as chemotherapy premedication are allowed) * Dermatologic conditions in the treatment area that could interfere with assessment (e.g., psoriasis, scleroderma, severe acne, chronic wounds) * Pre-existing dermatitis or significant skin lesions in the radiation field at baseline * Pregnancy or breastfeeding * Any other condition that, in the investigator's judgment, would compromise participation or confound the results Exclusion Criteria: \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Head and neck cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Alexandria University Main Hospitals
RECRUITINGAlexandria, Egypt
-
Ayady Almostakbal Hospital
RECRUITINGAlexandria, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A prospective imaging study of target definition and radiation planning workflows on the integrated TrueBeam-HyperSight system for patients receiving radiation therapy
- A prospective randomized controlled phase II trial of tai chi for Cancer-Related fatigue during radiotherapy in patients with head and neck malignancies
- Can a Self-Care program ease Post-Cancer swelling in the head and neck?
- Blood biomarkers may foreshadow Radiation-Induced dry mouth
- Can a new antibody help the immune system fight Hard-to-Treat tumors?
- Can a smart breathing device make life with a tracheostomy more comfortable?